Published in J Geriatr Psychiatry Neurol on January 01, 2000
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. Clin Ther (2010) 2.19
Quality of Life measures for dementia. Health Qual Life Outcomes (2003) 1.09
Everyday cognition in prodromal Huntington disease. Neuropsychology (2014) 0.81
The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults. Clin Neuropsychol (2014) 0.78
The validity of dependence as a health outcome measure in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2013) 0.77
Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease. Alzheimers Res Ther (2011) 0.77
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet (1997) 4.65
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54
Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat population. Pathology (1996) 1.82
The Canadian Neurological Scale: validation and reliability assessment. Neurology (1989) 1.78
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Multiple sclerosis and antecedent infections: a case-control study. Neurology (2000) 1.66
Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae. J Antimicrob Chemother (2000) 1.64
Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord (2001) 1.55
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53
HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. J Am Geriatr Soc (1997) 1.38
Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci (2001) 1.35
Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. J Am Geriatr Soc (1999) 1.32
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke (1986) 1.29
Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis. Disabil Rehabil (2002) 1.22
Social networks and self-rated health in two French-speaking Canadian community dwelling populations over 65. Soc Sci Med (2004) 1.19
Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J Am Geriatr Soc (2000) 1.17
The Canadian Study of Health and Aging: organizational lessons from a national, multicenter, epidemiologic study. Int Psychogeriatr (2001) 1.06
Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc (2000) 1.03
Studies in carcinogenesis: XI. Development of skin tumors in mice painted with 3:4-benzpyrene and creosote oil fractions. Am J Pathol (1940) 1.01
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
Observer variation in the classification of mammographic parenchymal patterns. J Chronic Dis (1986) 1.01
Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Br J Psychiatry (1995) 0.97
Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl (2008) 0.97
A case of bilateral frontal tumors without "frontal syndrome". Neurocase (2013) 0.96
Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep) (2006) 0.96
Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology (1996) 0.94
Development of simple cognitive function measures in a community dwelling population of elderly in Spain. Int J Geriatr Psychiatry (2000) 0.93
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain (1996) 0.92
Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative study. Crit Rev Oncol Hematol (2009) 0.91
Hemostatic markers in acute transient ischemic attacks. Stroke (1994) 0.90
Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study. Crit Rev Oncol Hematol (2009) 0.90
Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol Infect (2001) 0.88
Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord (2011) 0.87
Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand (2002) 0.87
Hemostatic markers in patients at risk of cerebral ischemia. Stroke (2000) 0.85
Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study. Ann Oncol (2010) 0.85
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales. J Geriatr Psychiatry Neurol (2000) 0.85
A recommended method for obtaining the age at onset of dementia from the CSHA database. Int Psychogeriatr (2001) 0.85
Observer variation in the interpretation of xeromammograms. J Natl Cancer Inst (1982) 0.84
A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer's disease: are they protective? Neuroepidemiology (2002) 0.84
High-dose progesterone infusion in healthy males: evidence against antiglucocorticoid activity of progesterone. Eur J Endocrinol (1995) 0.83
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J Geriatr Psychiatry Neurol (2000) 0.82
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review. Eur J Neurol (2014) 0.81
A Markov model of the natural history of multiple sclerosis. Neuroepidemiology (1985) 0.80
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl (2012) 0.80
Reliable individual change scores on the 3MS in older persons with dementia: results from the Canadian Study of Health and Aging. Int Psychogeriatr (2001) 0.79
Do patient factors alter the relationship between physician characteristics and use of long-acting benzodiazepines? J Clin Epidemiol (2000) 0.78
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients. NMR Biomed (1996) 0.77
Treatment comfort of adult neurologists in childhood onset conditions. Can J Neurol Sci (2012) 0.77
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.76
High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates. BMC Geriatr (2001) 0.76
Interobserver variability in the interpretation of contrast venography, technetium-99m red blood cell venography and impedance plethysmography for deep vein thrombosis. Can Assoc Radiol J (1990) 0.76
Elements of mobility as predictors of survival in elderly patients with dementia: findings from the Canadian Study of Health and Aging. Chronic Dis Can (2000) 0.76
Latent periods in multiple sclerosis. Neuroepidemiology (1996) 0.75
Properties and nucleotide sequence of a mitochondrial plasmid from sunflower. Curr Genet (1989) 0.75
Cytoplasmic male sterility in sunflower: comparison of molecular biology and genetic studies. Plant Mol Biol (1991) 0.75
Review of outcome measurement instruments in Alzheimer's disease drug trials: introduction. J Geriatr Psychiatry Neurol (2000) 0.75
Is multiple sclerosis an infectious disease? Inference about an input process based on the output. Biometrics (1990) 0.75
Properties of spermatozoa in relation to their elimination after vasectomy. Arch Androl (1979) 0.75
Mathematical models and individualized outcome estimates in multiple sclerosis. Biomed Pharmacother (1989) 0.75
Nucleotide sequence and transcriptional analysis of a mitochondrial plasmid from a cytoplasmic male-sterile line of sunflower. Theor Appl Genet (1991) 0.75
Technetium-99m red blood cell venography in patients with clinically suspected deep vein thrombosis: a prospective study. J Nucl Med (1988) 0.75
Harmonization: a methodology for advancing research in multiple sclerosis. Acta Neurol Scand Suppl (2012) 0.75
Canine distemper virus and multiple sclerosis. Neurology (1997) 0.75
Molecular analysis of the mitochondrial genome of Helianthus annuus in relation to cytoplasmic male sterility and phylogeny. Theor Appl Genet (1987) 0.75
[Epidemiology of breast feeding among mothers in a region of Montreal]. Union Med Can (1980) 0.75